Growing community of inventors

Milan, Italy

Giovanni Paganelli

Average Co-Inventor Count = 2.67

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 12

Giovanni PaganelliMarco Chinol (5 patents)Giovanni PaganelliMauro Ginanneschi (3 patents)Giovanni PaganelliPaolo Carminati (2 patents)Giovanni PaganelliUmberto Veronesi (1 patent)Giovanni PaganelliSergio Cafaggi (0 patent)Giovanni PaganelliPaola Cirrincione (0 patent)Giovanni PaganelliBrunella Parodi (0 patent)Giovanni PaganelliGabriele Caviglioli (0 patent)Giovanni PaganelliEleonora Russo (0 patent)Giovanni PaganelliGiovanni Paganelli (6 patents)Marco ChinolMarco Chinol (5 patents)Mauro GinanneschiMauro Ginanneschi (3 patents)Paolo CarminatiPaolo Carminati (37 patents)Umberto VeronesiUmberto Veronesi (1 patent)Sergio CafaggiSergio Cafaggi (0 patent)Paola CirrincionePaola Cirrincione (0 patent)Brunella ParodiBrunella Parodi (0 patent)Gabriele CaviglioliGabriele Caviglioli (0 patent)Eleonora RussoEleonora Russo (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Sigma-tau Industrie Farmaceutiche Riunite S.p.a. (6 from 343 patents)

2. UniversitÁ Degli Studi Di Genova (24 patents)

3. Istituto Europeo Di Oncologia S.r.l. (10 patents)


6 patents:

1. 8292869 - Container for vial of radiopharmaceutical and set for its infusion in a patient or for its transfer elsewhere

2. 8044081 - Aminoderivative of biotin and their conjugates with macrocyclic chelating agents

3. 7935346 - Medicament for the two-step perioperative therapy of solid tumours

4. 7842023 - Container for vial of radiopharmaceutical and set for its infusion in a patient or for its transfer elsewhere

5. 7816388 - Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents

6. 7390828 - Aminoderivatives of biotin and their conjugates with macrocyclic chelating agents

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/11/2025
Loading…